Disclosure Of Analysis Of Other Comprehensive Income By Item [Text Block]

Innate Pharma - Filing #2811003

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of analysis of other comprehensive income by item [text block]	—		—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of analysis of other comprehensive income by item [abstract]
Disclosure of analysis of other comprehensive income by item [line items]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	— EUR	276,000 EUR	718,000 EUR	— EUR	994,000 EUR	— EUR	— EUR	— EUR	— EUR	428,000 EUR	428,000 EUR	— EUR	—	— EUR	— EUR	— EUR
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income	—	— EUR	—	—	—	—	—	—	—	—	— EUR	—	—	—	—	—
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	— EUR	394,000 EUR	394,000 EUR	— EUR	— EUR	— EUR	— EUR	— EUR	— EUR	790,000 EUR	790,000 EUR	— EUR	— EUR	— EUR	— EUR	— EUR